Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®)

BACKGROUND: Despite the common use of topical ophthalmic corticosteroids in dogs, detailed reports on systemic and dermatologic adverse effects are limited. RESULTS: Nine purpose-bred research Beagles were treated with difluprednate 0.05% ophthalmic emulsion in one or both eyes 2–3 times daily. Some...

Descripción completa

Detalles Bibliográficos
Autores principales: Quantz, Katelin, Anderson, Amanda L., Harman, Christine D., Noland, Erica L., Del Valle, Jacquelyn M., Occelli, Laurence M., Burn, Jessica B., Petersen-Jones, Simon M., Langlois, Daniel K., Pirie, Chris G., Petersen, Annette D., Komáromy, András M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638448/
https://www.ncbi.nlm.nih.gov/pubmed/34847929
http://dx.doi.org/10.1186/s12917-021-03072-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638448/
https://www.ncbi.nlm.nih.gov/pubmed/34847929
http://dx.doi.org/10.1186/s12917-021-03072-9

Ejemplares similares